Combined with chemotherapy and immunotherapy, AstraZeneca’s Calquence reduced the risk of disease progression or death by 27% compared to placebo and chemoimmunotherapy in first-line mantle …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Researchers explore the secrets behind increased life expectancies, focusing on the influence of diet, lifestyle, and socio-economic changes. Centenarians, individuals living past 100, often delay
The brands are intended for four CNS disorders: anxiolytic, psycholeptic, anti-epileptic and anti-psychotic. Credit: OlgaReukova/Shutterstock.com. UK-based Pharmanovia has announced the acquisition of 11 central nervous
A large-scale clinical trial of treatment strategies for Crohn’s disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically